Literature DB >> 2235876

Stereochemical characterization of the diastereomers of the amobarbital N-glucosides excreted in human urine.

W H Soine1, P J Soine, F C Wireko, D J Abraham.   

Abstract

The stereochemistry associated with the amobarbital N-glucoside diastereomers (1a and 1b) that are excreted by humans in urine is unknown. Using X-ray crystallography, the absolute configuration of 1b was determined to be S (C-5 position of the barbiturate ring). Following oral administration of amobarbital to Caucasians and Orientals, from 5 to 25% of the dose of amobarbital was excreted in the urine as 1b. The other diastereomer, 1a, accounted for less than 0.1 to 0.2% of the dose in four individuals, with none detected in nine individuals. The rate constants, kf,1b, determined from the urinary excretion of 1b were lower than those previously reported for unresolved amobarbital N-glucosides. However, based on the urinary excretion of 1b, the rate constants, K, for elimination of amobarbital in Caucasians and Orientals were similar to those previously determined from the serum levels of amobarbital and the urinary excretion of unresolved amobarbital N-glucosides. In previous studies of the N-glucosylation of amobarbital, it is likely that a single N-glucose diastereomer, 1b, was being observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2235876     DOI: 10.1023/a:1015900629690

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  High-performance liquid chromatographic determination of the diastereomers of 1-(beta-D-glucopyranosyl)amobarbital in urine.

Authors:  P J Soine; W H Soine
Journal:  J Chromatogr       Date:  1987-11-27

2.  The excretion of hydroxyamylobarbitone in man after oral administration of amylobarbitone and hydroxyamylobarbitone.

Authors:  J Grove; P A Toseland
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

3.  The influence of dose on the distribution and elimination of amylobarbitone in healthy subjects.

Authors:  K Balasubramaniam; G E Mawer; P J Simons
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

4.  Product enantioselectivity in the N-glucosylation of amobarbital.

Authors:  W H Soine; P J Soine; B W Overton; L K Garrettson
Journal:  Drug Metab Dispos       Date:  1986 Sep-Oct       Impact factor: 3.922

5.  An assessment of short-cut procedures for studying drug metabolism in vivo using amobarbital as a model drug.

Authors:  B K Tang; W Kalow; L Endrenyi; F Y Chan
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  A method for studying drug metabolism in populations: racial differences in amobarbital metabolism.

Authors:  W Kalow; B K Tang; D Kadar; L Endrenyi; F Y Chan
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

7.  Kinetic considerations relating to the accrual and elimination of drug metabolites.

Authors:  A J Cummings; B K Martin; G S Park
Journal:  Br J Pharmacol Chemother       Date:  1967-02

8.  The effect of age on the hydroxylation of amylobarbitone sodium in man.

Authors:  R E Irvine; J Grove; P A Toseland; J R Trounce
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

9.  Stereochemical characterization of the diastereomers of the phenobarbital N-beta-D-glucose conjugate excreted in human urine.

Authors:  W H Soine; P J Soine; S E Mongrain; T M England
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

10.  Stability of phenobarbital N-glucosides: identification of hydrolysis products and kinetics of decomposition.

Authors:  F B Vest; W H Soine; R B Westkaemper; P J Soine
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

View more
  2 in total

1.  Identification of the diastereomers of pentobarbital N-glucosides excreted in human urine.

Authors:  W H Soine; P J Soine; T M England; R M Graham; G Capps
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

2.  Phenobarbital N-glucosylation by human liver microsomes.

Authors:  Sheela G Paibir; William H Soine; Diana F Thomas; Robert A Fisher
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.